Literature DB >> 31259696

Comparative evaluation of the use of dry binders in a physical mixture or as a coprocessed dry binder in matrix tablets with extended drug release.

Jitka Mužíková1, Alena Komersová2, Václav Lochař2, Lucie Vildová1, Bára Vošoustová2, Martin Bartoš3.   

Abstract

This paper evaluates and compares the properties of directly compressible tabletting materials and matrix tablets containing a combination of α-lactose monohydrate and microcrystalline cellulose in the 3:1 ratio in a physical mixture and in a coprocessed dry binder. Tested parameters include flow properties, compressibility, compactibility and the rate of drug release from tablets. Compressibility is evaluated by means of the energy profile of the compression process. Compactibility is evaluated by means of the tensile strength of the tablets. Dissolution testing is done using the rotating basket method. Dissolution profiles are evaluated by non-linear regression analysis. Total energy of compression and plasticity values were higher in tabletting materials with the coprocessed dry binder. Increasing additions of polyvinyl alcohol decreased the values of total energy of compression, plasticity, tensile strength of tablets and drug release rate. Dissolution behaviour of tablets, which contained the physical mixture or coprocessed dry binder and the same amount of polyvinyl alcohol, was comparable.

Entities:  

Keywords:  coprocessed dry binder; dissolution testing; energy profile of compression; matrix tablets; polyvinyl alcohol; tensile strength of tablets

Mesh:

Substances:

Year:  2018        PMID: 31259696     DOI: 10.2478/acph-2018-0030

Source DB:  PubMed          Journal:  Acta Pharm        ISSN: 1330-0075            Impact factor:   2.230


  1 in total

1.  3D-Printed Coating of Extended-Release Matrix Tablets: Effective Tool for Prevention of Alcohol-Induced Dose Dumping Effect.

Authors:  Barbora Skalická; Kevin Matzick; Alena Komersová; Roman Svoboda; Martin Bartoš; Luděk Hromádko
Journal:  Pharmaceutics       Date:  2021-12-09       Impact factor: 6.321

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.